312169
Empowering Free Clinics to Address Prediabetes
This AMA identified 8 physician-led free clinics across the country to implement a prediabetes education and screening protocol to identify and treat those at the greatest risk. The AMA Free Clinic initiative focuses on establishing onsite lifestyle coaches to offer the DPP onsite and integrate it with ongoing medical care. A study conducted by Bettina Tahsin et al found that the adoption of a combined lifestyle counseling/provider-patient reinforcement intervention showed significant reduction uncontrolled risk factors and improved outcomes. This session will explore the ability for a community-based clinic to address disparities in diabetes by adopting a prevention framework and focusing on prediabetes.
Learning Areas:
Administer health education strategies, interventions and programsChronic disease management and prevention
Diversity and culture
Planning of health education strategies, interventions, and programs
Program planning
Learning Objectives:
Describe the American Medical Association's Free Clinic Prediabetes Treatment Initiative
Identify the benefits of delivering a lifestyle intervention in conjunction with medical care
Discuss the opportunity to prevent diabetes in a non-threatening way to cultural diverse populations
Keyword(s): Chronic Disease Prevention, Health Care Access
Qualified on the content I am responsible for because: I have been developing and implementing health intervention programs to develop and enhance clinical and community linkages for more than 20 years. My primary area of focus is working with clinical practices to integrate lifestyle counseling into patient encounters and arrange for referral to community-based interventions. I have developed initiatives addressing tobacco use and secondhand smoke exposure on low income families,and addressing the availability of lifestyle programs for low income people at risk for diabetes.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.